The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
dc.rights.license | open | en_US |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | MALVY, Denis | |
dc.contributor.author | TABURET, A. M. | |
dc.contributor.author | DE LAMBALLERIE, X. | |
dc.contributor.author | MENTRE, F. | |
dc.contributor.author | EXTRAMIANA, F. | |
dc.date.accessioned | 2021-02-04T14:40:26Z | |
dc.date.available | 2021-02-04T14:40:26Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1935-2727 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/26136 | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | IDLIC | |
dc.title.en | The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers | |
dc.title.alternative | PLoS Negl Trop Dis | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1371/journal.pntd.0008259 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 32584817 | en_US |
bordeaux.journal | PLoS Neglected Tropical Diseases | en_US |
bordeaux.page | e0008259 | en_US |
bordeaux.volume | 14 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - U1219 | en_US |
bordeaux.issue | 6 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | IDLIC | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.export | false | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS%20Neglected%20Tropical%20Diseases&rft.date=2020&rft.volume=14&rft.issue=6&rft.spage=e0008259&rft.epage=e0008259&rft.eissn=1935-2727&rft.issn=1935-2727&rft.au=MALVY,%20Denis&TABURET,%20A.%20M.&DE%20LAMBALLERIE,%20X.&MENTRE,%20F.&EXTRAMIANA,%20F.&rft.genre=article |